First use of a video to assist the informed consent process in a randomized controlled trial in Japan
- 28 Downloads
In the United States, visual instruction using videos to describe health care services in general, and for acquiring informed consent in randomized controlled trials, is becoming routine. This paper reports the first use of video in a randomized trial in Japan.
A video designed to describe treatment options to patients for prerandomization in a controlled trial for prostate cancer treatments was produced and distributed. Physicians participating in the trial were surveyed by questionnaire regarding the use of the video.
Of 47 eligible patients with prostate cancer, enrolled in this trial between 1992 and 1994, 20 patients (43%) viewed the video and 27 patients (57%) received all information from the physician. The objective of this study was to determine if viewing the video influenced the patient's desire to express a choice between treatment options. After receiving the information, 11 of 20 patients (55%) who viewed the video, and 22 of 27 patients (81%) who did not view the video, expressed a preference. The difference in expression of a treatment preference between patients in each group was not significant. When the responses of all the patients in the trial are combined, 33 of 47 patients (70%) expressed a treatment preference.
The benefits of providing information regarding treatment options in a video format, compared to other means of explanation, remains to be elucidated. However, videos may be a preferable method for acquiring informed consent from patients participating in randomized control trials.
Key wordsconsent prostate cancer video
Unable to display preview. Download preview PDF.
- 1.The Council for International Organizations of Medical Sciences in collaboration with the World Health Organization. International Ethical Guidelines for Biomedical Research Involving Human Subjects. Geneva, 1993.Google Scholar
- 2.Royal College of Physicians. Guidelines on the Practice of Ethics Committees in Medical Research Involving Human Subjects. 2nd ed. London; RCP, 1990.Google Scholar
- 3.Japan Society of Clinical Oncology. Guideline on the Practice of Clinical Trials with Special Emphasis on Phase III Trials. J Jpn Soc Cancer Ther 1997;32:67–114 (in Japanese).Google Scholar
- 5.Shinoda M, Ohota K, Kobayashi T, Hyodo I, Watanabe T, Eguchi K. Doctors' dilemma of the informed consent in cancer clinical trials: the results of questionnaires for Japanese oncologists. Proc Jpn Cancer Assoc 1994;633.Google Scholar
- 10.Fisher WB, Cohen SJ, Hammond MK, Turner S, Loehrer PJ. Clinical trials in cancer therapy: effects to improve patient enrollment by community oncologists. Med Pediat Oncol 1991;19:165–168.Google Scholar
- 12.Aaronson NK, Visser-Pol E, Leenhouts GHMW, Muller MJ, van der Schot ACM, van Dam FSAM, Kues RB, Koning CCE, Huinink WWB, van Dongen JA, Dubbelman R. Telephone-based nursing intervention improves the effectiveness of the informed consent process in cancer clinical trials. J Clin Oncol 1996;14:984–996.PubMedGoogle Scholar
- 17.Japanese Urological Association and the Japanese Pathological Society. General Rules for, Clinical and Pathological Studies on Prostate Cancer. Kanehara, Tokyo, 1985.Google Scholar
- 20.Hamajima N. Randomized controlled trials on post-marketing drugs for cancer patients and informed consent. J Jpn, Soc Cancer Ther 1992;27:1701–1706 (in Japanese).Google Scholar